The Food and Drug Administration on Thursday approved sales of Genvoya from Gilead Sciences Inc. , the top maker of HIV medicines. The once-a-day pill combines three existing Gilead HIV drugs – Vitekta, Tybost and Emtriva – with a new version of tenofovir, the active ingredient in Gilead’s widely used Viread.
Are you up for a challenge?
